Evidence map›Paper›PMID 33966633›Full record

ArticleBMC biology2021

Natural abundance isotope ratios to differentiate sources of carbon used during tumor growth in vivo.

Petter Holland, William M Hagopian, A Hope Jahren, Tor Erik Rusten

Abstract read
In one paragraph

Article in BMC biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. International journal of molecular sciences · 2021
    Review
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Petter HollandCentre for Cancer Cell Reprogramming, Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Montebello, N-0379, Oslo, Norway. petter.holland@medisin.uio.no.ORCID 0000-0002-5717-6985
William M HagopianCentre for Earth Evolution and Dynamics, University of Oslo, Blindern, N-0315, Oslo, Norway.
A Hope JahrenCentre for Earth Evolution and Dynamics, University of Oslo, Blindern, N-0315, Oslo, Norway.
Tor Erik RustenCentre for Cancer Cell Reprogramming, Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Montebello, N-0379, Oslo, Norway. t.e.rusten@medisin.uio.no.

Funding

Helse Sør-Øst RHF 2018083Norges Forskningsråd 223272Norges Forskningsråd 262652Norges Forskningsråd 276070
6 · The paper itself

Abstract

backgroundRadioactive or stable isotopic labeling of metabolites is a strategy that is routinely used to map the cellular fate of a selected labeled metabolite after it is added to cell culture or to the circulation of an animal. However, a labeled metabolite can be enzymatically changed in cellular metabolism, complicating the use of this experimental strategy to understand how a labeled metabolite moves between organs. These methods are also technically demanding, expensive and potentially toxic. To allow quantification of the bulk movement of metabolites between organs, we have developed a novel application of stable isotope ratio mass spectrometry (IRMS).

resultsWe exploit natural differences in

conclusionMeasuring tumor growth in a D. melanogaster larvae tumor model reveals that these tumors derive a majority of carbon from host sources. We believe the low cost and non-toxic nature of this methodology gives it broad applicability to study carbon flows between organs also in other animals and for a range of other biological questions.

Indexed as

NeoplasmsAnimalsCarbonCarbon IsotopesDrosophila melanogasterMass SpectrometryCarbonCarbon IsotopesCarbonCATSIRFluxFoodHostIRMSMetaboliteTransferTumor

Identifiers

PMID33966633
PMCPMC8108461

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.